The evolution of MetS triggered by the various pathogenic pathways culminates in a pro-inflammatory state that clarifies the increase in inflammatory markers such as interleukin 6 (IL-6), C-reactive protein (CRP) and tumor necrosis factor alpha (TNF-α) [16]. The gene discussed is IL6; the disease is metabolic syndrome.